Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Morris

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin LymphomaYasmin Reyal, Irfan Kayani, Adrian J C Bloor, et al.
Journal of Clinical Immunology|May 16, 2025
Correction to: Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Thomas A Fox, Valerie Massey, Charley Lever, et al.
Journal of Clinical Immunology|January 6, 2025
Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Thomas A Fox, Valerie Massey, Charley Lever, et al.
British Journal of Haematology|July 4, 2023
Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccinationChristopher L Pinder, Dylan Jankovic, Thomas A Fox, et al.
Nature Communications|October 3, 2019
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific functionSharyn Thomas, Fiyaz Mohammed, Rogier M Reijmers, et al.
Hemasphere|September 15, 2021
The EHA Research Roadmap: Immune-based Therapies for Hematological MalignanciesHermann Einsele, Javier Briones, Fabio Ciceri, et al.
The Journal of Allergy and Clinical Immunology|March 13, 2024
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemiaSameer Bahal, Marta Zinicola, Shefta E Moula, et al.
Journal of Clinical Immunology|May 17, 2022
Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and ChildhoodJames W Day, Reem Elfeky, Bethany Nicholson, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin LymphomaYasmin Reyal, Irfan Kayani, Adrian J C Bloor, et al.
Journal of Clinical Immunology|May 16, 2025
Correction to: Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Thomas A Fox, Valerie Massey, Charley Lever, et al.
Journal of Clinical Immunology|January 6, 2025
Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Thomas A Fox, Valerie Massey, Charley Lever, et al.
British Journal of Haematology|July 4, 2023
Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccinationChristopher L Pinder, Dylan Jankovic, Thomas A Fox, et al.
Nature Communications|October 3, 2019
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific functionSharyn Thomas, Fiyaz Mohammed, Rogier M Reijmers, et al.
Hemasphere|September 15, 2021
The EHA Research Roadmap: Immune-based Therapies for Hematological MalignanciesHermann Einsele, Javier Briones, Fabio Ciceri, et al.
The Journal of Allergy and Clinical Immunology|March 13, 2024
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemiaSameer Bahal, Marta Zinicola, Shefta E Moula, et al.
Journal of Clinical Immunology|May 17, 2022
Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and ChildhoodJames W Day, Reem Elfeky, Bethany Nicholson, et al.
Pageof 8